• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

基于文献计量分析的冠状病毒研究进展。

Research Progress of Coronavirus Based on Bibliometric Analysis.

机构信息

School of Medical Equipment, Shenyang Pharmaceutical University, Shenyang 110016, China.

Liaoning Medical Big Data and Artificial Intelligence Engineering Technology Research Center, Shenyang 110016, China.

出版信息

Int J Environ Res Public Health. 2020 May 26;17(11):3766. doi: 10.3390/ijerph17113766.

DOI:10.3390/ijerph17113766
PMID:32466477
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7312058/
Abstract

BACKGROUND

COVID-19 has become one of the most serious global epidemics in the 21st Century. This study aims to explore the distribution of research capabilities of countries, institutions, and researchers, and the hotspots and frontiers of coronavirus research in the past two decades. In it, references for funding support of urgent projects and international cooperation among research institutions are provided.

METHOD

the Web of Science core collection database was used to retrieve the documents related to coronavirus published from 2003 to 2020. Citespace.5.6.R2, VOSviewer1.6.12, and Excel 2016 were used for bibliometric analysis.

RESULTS

11,036 documents were retrieved, of which China and the United States have contributed the most coronavirus studies, Hong Kong University being the top contributor. Regarding journals, the has contributed the most, while in terms of researchers, Yuen Kwok Yung has made the most contributions. The proportion of documents published by international cooperation has been rising for decades. Vaccines for SARS-CoV-2 are under development, and clinical trials of several drugs are ongoing.

CONCLUSIONS

international cooperation is an important way to accelerate research progress and achieve success. Developing corresponding vaccines and drugs are the current hotspots and research directions.

摘要

背景

COVID-19 已成为 21 世纪最严重的全球传染病之一。本研究旨在探索过去 20 年来各国、各机构和研究人员的研究能力分布，以及冠状病毒研究的热点和前沿。文中提供了对紧急项目的资助支持和研究机构间国际合作的参考依据。

方法

利用 Web of Science 核心合集数据库检索了 2003 年至 2020 年发表的与冠状病毒相关的文献。使用 Citespace.5.6.R2、VOSviewer1.6.12 和 Excel 2016 进行了文献计量分析。

结果

共检索到 11036 篇文献，其中中国和美国对冠状病毒研究的贡献最大，香港大学是最主要的贡献者。就期刊而言，《柳叶刀》的贡献最大，而就研究人员而言，袁国勇的贡献最大。几十年来，国际合作发表的文献比例一直在上升。针对 SARS-CoV-2 的疫苗正在研发中，几种药物的临床试验正在进行。

结论

国际合作是加速研究进展和取得成功的重要途径。开发相应的疫苗和药物是当前的热点和研究方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd67/7312058/ec572ac83f88/ijerph-17-03766-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd67/7312058/f043d1e67ade/ijerph-17-03766-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd67/7312058/e8ab86340c0d/ijerph-17-03766-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd67/7312058/04efd3885dfd/ijerph-17-03766-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd67/7312058/7d8010d7d58b/ijerph-17-03766-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd67/7312058/57233d33d159/ijerph-17-03766-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd67/7312058/82bb08edebba/ijerph-17-03766-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd67/7312058/d591cebd32c3/ijerph-17-03766-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd67/7312058/b7998df3e964/ijerph-17-03766-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd67/7312058/e44f507e0744/ijerph-17-03766-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd67/7312058/ec572ac83f88/ijerph-17-03766-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd67/7312058/f043d1e67ade/ijerph-17-03766-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd67/7312058/e8ab86340c0d/ijerph-17-03766-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd67/7312058/04efd3885dfd/ijerph-17-03766-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd67/7312058/7d8010d7d58b/ijerph-17-03766-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd67/7312058/57233d33d159/ijerph-17-03766-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd67/7312058/82bb08edebba/ijerph-17-03766-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd67/7312058/d591cebd32c3/ijerph-17-03766-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd67/7312058/b7998df3e964/ijerph-17-03766-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd67/7312058/e44f507e0744/ijerph-17-03766-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd67/7312058/ec572ac83f88/ijerph-17-03766-g010.jpg

相似文献

1
Research Progress of Coronavirus Based on Bibliometric Analysis.基于文献计量分析的冠状病毒研究进展。
Int J Environ Res Public Health. 2020 May 26;17(11):3766. doi: 10.3390/ijerph17113766.
2
Twenty-Year Span of Global Coronavirus Research Trends: A Bibliometric Analysis.全球冠状病毒研究趋势的二十年跨度：文献计量分析。
Int J Environ Res Public Health. 2020 Apr 28;17(9):3082. doi: 10.3390/ijerph17093082.
3
[Visualization analysis on treatment of coronavirus based on knowledge graph].[基于知识图谱的冠状病毒治疗可视化分析]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Mar;32(3):279-286. doi: 10.3760/cma.j.cn121430-20200225-00200.
4
[Visual analysis of coronavirus disease 2019 (COVID-19) studies based on bibliometrics].基于文献计量学的2019冠状病毒病（COVID-19）研究可视化分析
Zhongguo Zhong Yao Za Zhi. 2020 May;45(10):2239-2248. doi: 10.19540/j.cnki.cjcmm.20200320.501.
5
Indian Publications on SARS-CoV-2: A bibliometric study of WHO COVID-19 database.印度关于严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的出版物：对世界卫生组织COVID-19数据库的文献计量学研究
Diabetes Metab Syndr. 2020 Sep-Oct;14(5):1171-1178. doi: 10.1016/j.dsx.2020.07.007. Epub 2020 Jul 10.
6
Coronavirus disease 2019: a bibliometric analysis and review.新型冠状病毒病 2019：文献计量分析与综述。
Eur Rev Med Pharmacol Sci. 2020 Mar;24(6):3411-3421. doi: 10.26355/eurrev_202003_20712.
7
Bibliometric and Visualization Analysis of Human Coronaviruses: Prospects and Implications for COVID-19 Research.文献计量学和人类冠状病毒的可视化分析：对 COVID-19 研究的展望和启示。
Front Cell Infect Microbiol. 2020 Sep 23;10:581404. doi: 10.3389/fcimb.2020.581404. eCollection 2020.
8
Bibliometric evaluation of Latin American contributions on COVID-19.拉丁美洲对新冠疫情贡献的文献计量学评估。
Biomedica. 2020 Oct 30;40(Supl. 2):104-115. doi: 10.7705/biomedica.5571.
9
Mapping the situation of research on coronavirus disease-19 (COVID-19): a preliminary bibliometric analysis during the early stage of the outbreak.绘制新型冠状病毒病（COVID-19）研究态势图：疫情爆发早期的初步文献计量分析。
BMC Infect Dis. 2020 Aug 1;20(1):561. doi: 10.1186/s12879-020-05293-z.
10
Citation Network Analysis of the Novel Coronavirus Disease 2019 (COVID-19).新型冠状病毒病 2019（COVID-19）的引文网络分析。
Int J Environ Res Public Health. 2020 Oct 21;17(20):7690. doi: 10.3390/ijerph17207690.

引用本文的文献

1
Scientific Mapping of Global Research on Health Equity by 2023: A Bibliometric Study.到2023年全球健康公平研究的科学图谱：一项文献计量学研究。
Health Sci Rep. 2025 Feb 19;8(2):e70478. doi: 10.1002/hsr2.70478. eCollection 2025 Feb.
2
Bibliometric Analysis of Human Metapneumovirus Studies.人偏肺病毒研究的文献计量分析
Infect Dis Clin Microbiol. 2023 Dec 29;5(4):311-322. doi: 10.36519/idcm.2023.250. eCollection 2023 Dec.
3
Global trends and future prospects of COVID-19 and physical activity: Bibliometric analysis.全球 COVID-19 与身体活动的趋势和未来展望：文献计量分析。

本文引用的文献

1
Universal use of face masks for success against COVID-19: evidence and implications for prevention policies.普遍使用口罩以成功应对 COVID-19：预防政策的证据和影响。
Eur Respir J. 2020 Jun 18;55(6). doi: 10.1183/13993003.01260-2020. Print 2020 Jun.
2
Phylogenetic network analysis of SARS-CoV-2 genomes.SARS-CoV-2 基因组的系统发育网络分析。
Proc Natl Acad Sci U S A. 2020 Apr 28;117(17):9241-9243. doi: 10.1073/pnas.2004999117. Epub 2020 Apr 8.
3
SARS-CoV-2 Vaccines: Status Report.SARS-CoV-2 疫苗：现状报告。
Medicine (Baltimore). 2023 Sep 29;102(39):e35316. doi: 10.1097/MD.0000000000035316.
4
Knowledge mapping of energy research in the hospitality industry to evaluation research collaboration.酒店业能源研究到评估研究合作的知识图谱。
Heliyon. 2023 May 26;9(6):e16591. doi: 10.1016/j.heliyon.2023.e16591. eCollection 2023 Jun.
5
Saliva-based detection of SARS-CoV-2: a bibliometric analysis of global research.基于唾液的 SARS-CoV-2 检测：全球研究的文献计量分析。
Mol Cell Biochem. 2024 Apr;479(4):761-777. doi: 10.1007/s11010-023-04760-w. Epub 2023 May 13.
6
Research trends on anti-PD-1/PD-L1 immunotherapy for esophageal cancer: A bibliometric analysis.食管癌抗PD-1/PD-L1免疫治疗的研究趋势：一项文献计量分析
Front Oncol. 2022 Nov 17;12:983892. doi: 10.3389/fonc.2022.983892. eCollection 2022.
7
Trends in Research about COVID-19 Vaccine Documented through Bibliometric and Visualization Analysis.通过文献计量学和可视化分析记录的COVID-19疫苗研究趋势
Healthcare (Basel). 2022 Oct 4;10(10):1942. doi: 10.3390/healthcare10101942.
8
Visualized analysis of research on helicopter emergency medical service.直升机紧急医疗服务研究的可视化分析。
Medicine (Baltimore). 2022 Sep 9;101(36):e30463. doi: 10.1097/MD.0000000000030463.
9
Bibliometric Analyses of Global Scholarly Output in Dentistry Related to COVID-19.与COVID-19相关的牙科领域全球学术产出的文献计量分析。
J Int Soc Prev Community Dent. 2022 Jan 29;12(1):100-108. doi: 10.4103/jispcd.JISPCD_294_21. eCollection 2022 Jan-Feb.
10
Research on Health Disparities Related to the COVID-19 Pandemic: A Bibliometric Analysis.新冠疫情相关健康差异研究：文献计量分析。
Int J Environ Res Public Health. 2022 Jan 22;19(3):1220. doi: 10.3390/ijerph19031220.
Immunity. 2020 Apr 14;52(4):583-589. doi: 10.1016/j.immuni.2020.03.007. Epub 2020 Apr 6.
4
COVID-19 Testing in South Korea: Current Status and the Need for Faster Diagnostics.韩国的新冠病毒检测：现状与对更快诊断方法的需求
Ann Lab Med. 2020 Sep;40(5):349-350. doi: 10.3343/alm.2020.40.5.349. Epub 2020 Mar 31.
5
Progress and Prospects on Vaccine Development against SARS-CoV-2.新型冠状病毒疫苗研发的进展与展望
Vaccines (Basel). 2020 Mar 29;8(2):153. doi: 10.3390/vaccines8020153.
6
[Progress and challenge of vaccine development against 2019-novel coronavirus (2019-nCoV)].[2019新型冠状病毒（2019-nCoV）疫苗研发的进展与挑战]
Zhonghua Yu Fang Yi Xue Za Zhi. 2020 Jun 6;54(6):614-619. doi: 10.3760/cma.j.cn112150-20200317-00366.
7
Insights from nanomedicine into chloroquine efficacy against COVID-19.纳米医学对氯喹治疗 COVID-19 疗效的启示。
Nat Nanotechnol. 2020 Apr;15(4):247-249. doi: 10.1038/s41565-020-0674-9.
8
Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine.抗2019冠状病毒病（COVID-19）的氨基喹啉：氯喹或羟氯喹。
Int J Antimicrob Agents. 2020 Apr;55(4):105945. doi: 10.1016/j.ijantimicag.2020.105945. Epub 2020 Mar 17.
9
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.洛匹那韦-利托那韦治疗成人重症 COVID-19 患者的临床试验。
N Engl J Med. 2020 May 7;382(19):1787-1799. doi: 10.1056/NEJMoa2001282. Epub 2020 Mar 18.
10
Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review.新型冠状病毒病（COVID-19）在早期暴发期间的流行病学、病因、临床表现和诊断、预防和控制：范围综述。
Infect Dis Poverty. 2020 Mar 17;9(1):29. doi: 10.1186/s40249-020-00646-x.